XML 59 R48.htm IDEA: XBRL DOCUMENT
v3.25.2

Stockholders' Equity (Deficit) (Details) |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Mar. 23, 2025 USD ($) $ / shares shares | Dec. 02, 2024 USD ($) $ / shares shares | Jul. 22, 2024 USD ($) $ / shares shares | Jan. 22, 2024 USD ($) $ / shares shares | Jun. 09, 2023 $ / shares shares | Dec. 31, 2023 $ / shares shares | Mar. 31, 2025 shares | Jun. 30, 2024 shares | Mar. 31, 2024 shares | Jun. 30, 2025 USD ($) Vote $ / shares shares | Jun. 30, 2024 USD ($) | Dec. 31, 2024 $ / shares shares | Feb. 25, 2025 $ / shares shares | Jan. 31, 2024 $ / shares shares | Feb. 16, 2023 $ / shares shares
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum number of shares which the Company is authorized to issue |  |  |  |  |  |  |  |  |  |  | 300,000,000 |  |  |  |  |
Preferred stock, par value (in dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 0.0001 |  | $ 0.0001 |  |  |
Preferred Stock, Shares Issued |  |  |  |  |  |  |  |  |  |  | 0 |  | 0 |  |  |
Common stock, shares issued |  |  |  |  |  |  |  |  |  |  | 833,683 |  | 36,753 |  |  |
Common stock, share outstanding |  |  |  |  |  |  |  |  |  |  | 833,683 |  | 36,753 |  |  |
Net proceeds from sales of common stock | $ |  |  |  |  |  |  |  |  |  |  | $ 8,854,797 | $ 6,872,339 |  |  |  |
Common Stock - Dividends and Voting |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash dividends were declared or paid | $ |  |  |  |  |  |  |  |  |  |  | $ 0 |  |  |  |  |
Common stock voting rights per share | Vote |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |
Series C warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |
Exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 69.67 |  |  | $ 438.9 |  |
Number of warrants purchased |  |  |  |  |  |  |  |  |  |  | 144,678 |  |  |  |  |
Series D warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 6 months |  |
Exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 438.90 |  |
Series A-1 Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  | $ 348.35 |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  |  |  |  |  | 55 |  |  |  |  |  |  |  |  |  |
Series A-2 Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  | $ 348.35 |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  |  |  |  |  | 55 |  |  |  |  |  |  |  |  |  |
June Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  | $ 161,700 |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  |  |
February Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 486,948
Number of warrants purchased |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1
December Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  |  |  |  |  | 9 |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  |  |  | $ 11,180.4 |  |  |  |  |  |  |  |  |
January Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 6 months |
Exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,127.28 |
Number of warrants purchased |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,864 |
January Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 6 months |
Exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 1,409.1 |  |  |  | $ 1,409.1 |
Number of warrants purchased |  |  |  |  |  |  |  |  |  |  | 386 |  |  |  | 386 |
Securities Purchase Agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of direct offering |  |  |  |  | 465 |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  |  | $ 348.35 |  | $ 1,127.28 |  |  |  |  |  |  |  |  |  |  |
Net proceeds from sales of common stock | $ |  |  | $ 7,200,000 |  | $ 6,100,000 |  |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  |  | 6,180 |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | Series C warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  | 22,966 |  |  |  |  |  |  |  |  |  | 22,966 |  |  |
Term of warrants |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  | $ 438.9 |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | Series D warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  | 22,966 |  |  |  |  |  |  |  |  |  | 22,966 |  |  |
Exercise price | $ / shares |  |  | $ 438.90 |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of common stock |  |  | 3 |  |  |  |  |  |  |  |  |  |  | 3 |  |
Securities Purchase Agreement | Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  | 16,786 |  | 5,968 |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  |  | $ 348.25 |  | $ 1,118.04 |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  | $ 0.0924 |  | $ 9.24 |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | January Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants sold |  |  |  |  | 12,864 |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  | 3 years 6 months |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  | $ 1,127.28 |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement | January Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Term of warrants |  |  |  |  | 3 years 6 months |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  |  | $ 1,409.1 |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  |  | 386 |  |  |  |  |  |  |  |  |  |  |
July 2024 Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds from sales of common stock | $ |  |  |  | $ 2,400,000 |  |  |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  |  |  | 10,823 |  |  |  |  |  |  |  |  |  |  |  |
Purchase price of per share | $ / shares |  |  |  | $ 277.2 |  |  |  |  |  |  |  |  |  |  |  |
July 2024 Offering | July Placement Agent Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  |  |  | $ 346.5 |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  |  |  | 542 |  |  |  |  |  |  |  |  |  |  |  |
March 2025 Registered Direct Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in dollars per share) | $ / shares |  | $ 27.44 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuances of common stock, net (in shares) |  | 366,072 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds | $ |  | $ 8,900,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 2025 Registered Direct Offering | Common Stock Purchase Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  | $ 24.08 |  |  |  |  |  |  |  |  |  |  |  |  |  |
March 2025 Registered Direct Offering | Placement agent warrants from February RDO |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price | $ / shares |  | $ 29.96 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants purchased |  | 366,072 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum number of shares which the Company is authorized to issue |  |  |  |  |  |  |  |  |  |  | 290,000,000 |  |  |  |  |
Issuances of common stock, net (in shares) | [1] |  |  |  |  |  |  | 796,930 | 1,577 | 5,607 |  |  |  |  |  |
Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum number of shares which the Company is authorized to issue |  |  |  |  |  |  |  |  |  |  | 10,000,000 |  |  |  |  |
[1] | On May 15, 2025, the Company effected a reverse split of the Company's common stock, either issued and outstanding or held by the Company as treasury stock. The May 2025 Reverse Split was at a ratio of one share for every 28 shares previously held with no change in the par value per share. The May 2025 Reverse Split did not change the number of authorized shares of common stock. All common stock share and per share data, and exercise price data for applicable common stock equivalents, included in these financial statements have been retroactively adjusted to reflect the Reverse Split.

X
- Definition Number of warrants or rights issued during the period. + References No definition available. + Details
Name: | rnaz_ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of votes that each common share is entitled. + References No definition available. + Details
Name: | rnaz_CommonStockNumberOfVotesPerShare
Namespace Prefix: | rnaz_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maximum number of shares which the Company is authorized to issue. + References No definition available. + Details
Name: | rnaz_MaximumNumberOfSharesWhichCompanyIsAuthorizedToIssue
Namespace Prefix: | rnaz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ClassOfStockLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 + Details
Name: | us-gaap_CommonStockSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 2 -SubTopic 405 -Topic 942 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2 + Details
Name: | us-gaap_DividendsCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 + Details
Name: | us-gaap_PreferredStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 + Details
Name: | us-gaap_PreferredStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_SeriesCWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_SeriesDWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_Seriesa1WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_Seriesa2WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_JunePlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_FebruaryPlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_DecemberPlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_JanuaryWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_JanuaryPlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rnaz_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rnaz_July2024OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_JulyPlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rnaz_March2025RegisteredDirectOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_CommonStockPurchaseWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rnaz_PlacementAgentWarrantsFromRdoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |